Archive
Home / Media Centre / Archive
Here you can find the archive of all Press Releases prior to 2022
Filter by date:
Showing 1107 press releases before 2022
-
AstraZeneca divestment of Movantik to RedHill Biopharma completed
-
Lokelma recommended for approval in EU for patients with hyperkalaemia on stable haemodialysis
-
Brilinta reduced bleeding vs dual therapy in high-risk coronary patients in sub-analyses from Phase IV TWILIGHT trial
-
Imfinzi approved in the US for extensive-stage small cell lung cancer
-
Farxiga Phase III DAPA-CKD trial will be stopped early after overwhelming efficacy in patients with chronic kidney disease
-
Farxiga reduced the incidence of heart failure worsening or cardiovascular death in a sub-analysis from landmark Phase III DAPA-HF trial
-
Lokelma approved in Japan for the treatment of hyperkalaemia
-
AstraZeneca to discover and develop siRNA therapeutics for Cardiovascular, Renal, Metabolic and Respiratory diseases in new collaboration
-
AstraZeneca to donate 9 million face masks to support healthcare workers around the world in the fight against COVID-19
-
Lynparza granted orphan drug designation in Japan for BRCA-mutated metastatic pancreatic cancer
Latest articles and press releases
All of our latest press releases and articles are available to explore
